Michael John Peagram is a British businessperson who has been at the helm of 5 different companies. Currently, Dr. Peagram is Chairman of Melchior Investissements & Industries SA and Non-Executive Chairman for Quixant Plc. Dr. Peagram is also on the board of CMS s.r.o., Mountmorris Developments Ltd., Valentia Properties Ltd. and Valentine Chemicals BVI.
He previously was Chairman for RMR Plc, Managing Director-Chemical Division at Croda International Plc, Chairman at CRC Group Plc, Deputy Chairman for Holliday Chemical Holdings Plc and Managing Director-Chemical Division at Pfizer Ltd.
He received an MBA from Manchester Business School and a doctorate from the University of Oxford.